Contents

Current Pharmaceutical Design, Volume 19 - Number 14

Editorial

Editorial (Hot Topic: Flavoproteins and Flavoenzymes with Biomedical and Therapeutic Impact)

, 19(14): 2497 - 2498

Milagros Medina, Patricia Ferreira and Marta Martinez-Julvez


DOI: 10.2174/1381612811319140001




D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy

, 19(14): 2499 - 2511

Silvia Sacchi, Elena Rosini, Loredano Pollegioni and Gianluca Molla


DOI: 10.2174/1381612811319140002




1,4-Naphthoquinones and Other NADPH-Dependent Glutathione Reductase- Catalyzed Redox Cyclers as Antimalarial Agents

, 19(14): 2512 - 2528

Didier Belorgey, Don Antoine Lanfranchi and Elisabeth Davioud-Charvet


DOI: 10.2174/1381612811319140003




Inhibitor Design for Monoamine Oxidases

, 19(14): 2529 - 2539

Rona R. Ramsay


DOI: 10.2174/1381612811319140004




Is Renalase a Novel Player in Catecholaminergic Signaling? The Mystery of the Catalytic Activity of an Intriguing New Flavoenzyme

, 19(14): 2540 - 2551

Sara Baroni, Mario Milani, Vittorio Pandini, Giulio Pavesi, David Horner and Alessandro Aliverti


DOI: 10.2174/1381612811319140005




Riboflavin Analogs as Antiinfectives: Occurrence, Mode of Action, Metabolism and Resistance

, 19(14): 2552 - 2560

Danielle Biscaro Pedrolli, Frank Jankowitsch, Julia Schwarz, Simone Langer, Shinobu Nakanishi, Eva Frei and Matthias Mack


DOI: 10.2174/1381612811319140006




Targeting UDP-Galactopyranose Mutases from Eukaryotic Human Pathogens

, 19(14): 2561 - 2573

Karina Kizjakina, John J. Tanner and Pablo Sobrado


DOI: 10.2174/1381612811319140007




Methylenetetrahydrofolate Reductase: Biochemical Characterization and Medical Significance

, 19(14): 2574 - 2593

Elizabeth E. Trimmer


DOI: 10.2174/1381612811319140008




Redox Proteins as Targets for Drugs Development Against Pathogens

, 19(14): 2594 - 2605

Daniela L. Catalano-Dupuy, Arleth Lopez-Rivero, Anabel Soldano and Eduardo A. Ceccarelli


DOI: 10.2174/1381612811319140009




Chemical Nature and Reaction Mechanisms of the Molybdenum Cofactor of Xanthine Oxidoreductase

, 19(14): 2606 - 2614

Ken Okamoto, Teruo Kusano and Takeshi Nishino


DOI: 10.2174/1381612811319140010




Target Sites for the Design of Anti-trypanosomatid Drugs Based on the Structure of Dihydroorotate Dehydrogenase

, 19(14): 2615 - 2627

Matheus Pinto Pinheiro, Flavio da Silva Emery and M. Cristina Nonato


DOI: 10.2174/1381612811319140011




The Oxido-reductase Activity of the Apoptosis Inducing Factor: A Promising Pharmacological Tool?

, 19(14): 2628 - 2636

Patricia Ferreira, Raquel Villanueva, Lauriane Cabon, Santos A. Susin and Milagros Medina


DOI: 10.2174/1381612811319140012




The Prokaryotic FAD Synthetase Family: A Potential Drug Target

, 19(14): 2637 - 2648

Ana Serrano, Patricia Ferreira, Marta Martinez-Julvez and Milagros Medina


DOI: 10.2174/1381612811319140013




Biosynthesis of Flavin Cofactors in Man: Implications in Health and Disease

, 19(14): 2649 - 2675

Maria Barile, Teresa Anna Giancaspero, Carmen Brizio, Concetta Panebianco, Cesare Indiveri, Michele Galluccio, Lodovica Vergani, Ivano Eberini and Elisabetta Gianazza


DOI: 10.2174/1381612811319140014




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science